Low prevalence of biliary tract cancer with defective mismatch repair genes in a Japanese hospital‑based population
Yasuhisa Ando
◽
Kensuke Kumamoto
◽
Hiroyuki Matsukawa
◽
Ryou Ishikawa
◽
Hironobu Suto
◽
...
C. Vivaldi
◽
C. Ugolini
◽
G. Orsi
◽
V. Formica
◽
S. Catanese
◽
...
Ryuichiro Suda
◽
Nozomu Sakai
◽
Kazuyuki Matsushita
◽
Takayuki Ishige
◽
Yohei Kawasaki
◽
...
2009 ◽
Vol 7
(2)
◽
pp. 114
J. Rhee
◽
Y.J. Kim
◽
S.A. Im
◽
S.W. Han
◽
K.W. Lee
◽
...
2002 ◽
Vol 29
(6U)
◽
pp. 51-53
◽
J Harder
◽
O Waiz
◽
M Geissler
◽
HE Blum
◽
A Schmitt-Gräff
◽
...
C Mayr
◽
A Wagner
◽
D Neureiter
◽
M Pichler
◽
M Ritter
◽
...
Orphan designation: (5R,5aR,8aR,9S)-9-[[4,6-O-[(R)-Ethylidene]-β-D-glucopyranosyl]-oxy]-5-(4-({[(2,2-dimethyl-1,3-dioxolan-4-yl)methoxy]carbonyl}oxy)-3,5-dimethoxyphenyl)-5,8,8a,9-tetrahydroisobenzofuro[5,6-f][1,3]benzodioxol-6(5aH)-one (etoposide toniribate), Treatment of biliary tract cancer